Psychedelic and MDMA-Related Adverse Effects-A Call for Action.
Otto Simonsson, Matthew W. Johnson, Peter S. Hendricks
JAMA Health Forum November 1, 2024 DOI: 10.1001/jamahealthforum.2024.3630 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Viewpoint Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy MDMA |
| Keywords | Adverse effects Patient safety Preparation & integration |
| Citations | 10 |
| Key points | Better understanding of risks associated with psychedelic and MDMA use is needed, and four key research goals are identified to ensure safe and ethical practice. |
Abstract
This Viewpoint discusses the need to better understand potential risks associated with psychedelic and 3,4-methylenedioxymethamphetamine (MDMA) use to ensure safe and ethical practice and identifies 4 key research goals.